Tracer library / [188Re]Re-C1P5

[188Re]Re-C1P5

Also written as [188Re]Re-C1P5

Radionuclide: Re-188
Modality: —
Production route: —
Stage: Preclinical
Syntheses indexed: 0

Gynaecological cancer Dosimetry and biodistribution studies

What it is

Compound class: Monoclonal antibody (radioimmunoconjugate)
Target / mechanism: HPV16 E6 oncoprotein PMID 20861673
Clinical application: Cervical cancer associated with HPV16 infection PMID 20861673
Theranostic pair: —

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [188Re]Re-C1P5, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 20861673, 26625938. Stage set/updated at stage 39 from PMID 20861673: 'We initiated SiHa tumors in nude mice, radiolabeled C1P5 mAb to E6 with a beta-emitter 188-Rhenium (¹⁸⁸Re) and treated tumor-bearing mice'.